Such inhibitor compounds will serve as chemical biology tools for pharmacological target validation in terms of Mnk's role in regulation of Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways in cancers, as well as their functions required for normal physiological process. This evidence concerns the gene MTOR and cancer.